| 75 | 0 | 62 |
| 下载次数 | 被引频次 | 阅读次数 |
瘀血的生成始于虚劳所致气血乏源、运行失畅,虚损与瘀滞燥结生化干血,复因邪热蒸煽演化劳瘵,而形成“虚劳-干血-劳瘵”的传变路径。文章基于瘀血病理要素在原发性骨髓纤维化的生成、发展与演变过程中的主体地位,探讨原发性骨髓纤维化病机及辨证思路,认为疾病发生以虚劳内生为本,疾病成形以干血内结为常,疾病转化以劳瘵内化为变,对其治疗应兼顾扶正与祛邪两方面,纤维化前期根于固本清源,明显纤维化期治以缓中补虚,疾病进展转白重在养阴解毒。附验案1则。
Abstract:The formation of blood stasis begins with the deficiency of qi and blood due to consumptive disease,which leads to the lack of source and poor circulation of qi and blood. Deficiency and weakness,as well as blood stasis and dryness,generate dry blood. Subsequently,due to the steam and dampness of pathogenic heat,it evolves into chronic infectious disease,thus forming a transmission and transformation path of “consumptive disease-dry blood-chronic infectious disease”. Based on the dominant position of the pathological elements of blood stasis in the generation,development and evolution of primary myelofibrosis,this article explores the pathogenesis and syndrome differentiation and treatment of primary myelofibrosis. It holds that the onset of the disease is based on internal deficiency and fatigue,the formation of the disease is often due to the internal formation of dry blood,and the transformation of the disease is due to internal consumption,which leads to chronic infectious disease. The treatment of this disease should take into account both strengthening the body's resistance and eliminating pathogenic factors. In the early stage of fibrosis,the basic treatment lies in strengthening the body and clearing the source. During the obvious fibrosis stage,the treatment should focus on gradual recovery and tonifying deficiency. When the disease progresses and turns into leukemia,the key is to nourish yin and detoxify. One test case is attached.
[1]PASSAMONTI F,MORA B. Myelofibrosis[J]. Blood,2023,141(16):1954-1970.
[2]TEFFERI A. Primary myelofibrosis:2023 update on diagnosis,risk-stratification,and management[J]. American J Hematol,2023,98(5):801-821.
[3]GARMEZY B,SCHAEFER J K,MERCER J,et al. A provider’s guide to primary myelofibrosis:pathophysiology,diagnosis,and management[J]. Blood Rev,2021,45:100691.
[4]蓝海,侯丽,郎海燕,等.常见血液病的中医分类与命名[J].中医杂志,2019,60(9):750-753,778.
[5]张仲景.金匮要略[M].何任,何若苹,整理.北京:人民卫生出版社,2005:24.
[6]桑红灵,戴天木.《金匮要略》干血病的病机浅析[J].中华中医药杂志,2021,36(6):3673-3675.
[7]陈无择.三因极一病证方论[M].王象礼,张玲,赵怀舟,校注.北京:中国中医药出版社,2007:186.
[8]沈金鳌.杂病源流犀烛[M].田思胜,整理.北京:人民卫生出版社,2006:232.
[9]唐宗海.血证论[M].魏武英,李佺,整理.北京:人民卫生出版社,2005.
[10]王子接.绛雪园古方选注[M]. 3版.李飞,武丹丹,黄琼磁,校注.北京:中国中医药出版社,2007:149.
[11]汪绮石.理虚元鉴[M].谭克陶,周慎,整理.北京:人民卫生出版社,2005.
[12]孙一卓,杨宇杰,李丽,等.原发性骨髓纤维化的发病机制及诊疗研究进展[J].中国优生与遗传杂志,2023,31(4):665-672.
[13]李中梓.医宗必读[M].郭霞珍,王志飞,袁卫玲,等整理.北京:人民卫生出版社,2023:255-256.
[14]卓秋燕,代喜平.运用《金匮要略》虚劳理论探讨原发性骨髓纤维化的辨治[J].中医药导报,2019,25(8):120-121,125.
[15]马慧淼,谌海燕,郭明,等.基于虚劳理论探讨骨髓增生异常综合征的分阶段论治[J].环球中医药,2023,16(8):1628-1630.
[16]姜天叙.风劳臌膈四大证治[M].南京:江苏科学技术出版社,2013:24.
[17]林珮琴.类证治裁[M].李德新,整理.北京:人民卫生出版社,2005:77.
[18]赵智强,李嘉.略论周仲瑛教授的“癌毒”学说及其临床运用[J].新中医,1998,30(10):6-8.
[19]RUMI E,SANT’ANTONIO E,BOVERI E,et al. Diagnosis and management of prefibrotic myelofibrosis[J].Expert Rev Hematol,2018,11(7):537-545.
[20]纪云飞,王瑞君,李晓波.复方四君子汤的化学成分和药理作用研究进展[J].中草药,2016,47(5):837-843.
[21]申晓芳,金华.黄芪、党参药理归经作用和临床应用[J].实用中医内科杂志,2012,26(7):75,77.
[22]聂欣,成颜芬,王琳,等.桃红四物汤化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析[J].中国实验方剂学杂志,2020,26(4):226-234.
[23]苏浩杰,戴晓峰,吴建伟.李达辨治原发性骨髓纤维化经验[J].山东中医杂志,2023,42(1):62-66.
[24]徐爽,李志鸣,钟相根.《金匮要略》大黄䗪虫丸“缓中补虚”探析[J].中医学报,2020,35(1):23-26.
[25]秦宝宁.大黄䗪虫丸加减方治疗BCR/ABL阴性骨髓增殖性肿瘤的临床与实验研究[D].济南:山东中医药大学,2016.
[26]曹晓靖.基于基因/蛋白质相互作用网络探索大黄䗪虫丸治疗原发性骨髓纤维化的机理[D].济南:山东中医药大学,2017.
[27]朱丹溪.丹溪心法[M].田思胜,校注.北京:中国中医药出版社,2008:78.
[28]张介宾.景岳全书[M].李继明,王大涥,王小平,等整理.北京:人民卫生出版社,2007:362.
[29]王佳雯,翟永松,王满元,等.《温病条辨》青蒿鳖甲汤现代药理及临床应用研究进展[J].实用中医内科杂志,2016,30(7):95-98.
[30]黄礼明,胡莉文,陈怡宏,等.加味青蒿鳖甲汤含药血清对K562细胞株增殖周期及凋亡率的影响[J].贵阳中医学院学报,2008,30(6):75-78.
[31]陈明贵,黄礼明,尹尚瑾,等.加味青蒿鳖甲汤含药血清对白血病CEM细胞株增殖及凋亡的研究[J].贵阳中医学院学报,2019,41(3):22-27,32.
[32]尹尚瑾,黄礼明,常宝珠,等.加味青蒿鳖甲汤对急性髓性白血病完全缓解患者CD34+源树突细胞诱导过程中IL-6的影响[J].中西医结合研究,2022,14(1):10-15.
[33]尹尚瑾,黄礼明,陈明贵,等.加味青蒿鳖甲汤对急性T淋巴细胞白血病完全缓解患者骨髓CD34+细胞源树突细胞生物学效应的影响[J].中华中医药杂志,2019,34(12):5881-5885.
基本信息:
DOI:10.16295/j.cnki.0257-358x.2026.02.007
中图分类号:R259
引用信息:
[1]李昕,陈斌.基于“虚劳-干血-劳瘵”辨治原发性骨髓纤维化[J].山东中医杂志,2026,45(02):150-155.DOI:10.16295/j.cnki.0257-358x.2026.02.007.
基金信息:
中华中医药学会血液病优势病种相关临床应用基础研究项目(编号:202169-003)
2024-10-30
2024
2024-11-25
2024
1
2026-02-05
2026-02-05